Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Cesar Homero Gutierrez-Aguirre"'
Reassessing blood product irradiation in haploidentical transplantation: a single-center perspective
Autor:
Juan Pablo Martínez-Hernández, Yesica A. López-Mora, Rosario Salazar-Riojas, Dalila Marisol Alvarado Navarro, Ana Karen Hernández-Navarro, Yair Omar Chavez-Estrada, Andrés Gómez-De León, Cesar Homero Gutierrez-Aguirre, Perla R. Colunga-Pedraza, Olga Graciela Cantú-Rodríguez, José Carlos Jaime-Pérez, David Gomez-Almaguer
Publikováno v:
Hematology, Vol 29, Iss 1 (2024)
Objectives: The main objective was to investigate the incidence of transfusion-associated graft-versus-host disease (TA-GVHD) in patients who underwent haploidentical hematopoietic cell transplants (HCT) and received non-irradiated leukoreduced blood
Externí odkaz:
https://doaj.org/article/1aff226ef903455e812425f445d58211
Autor:
Perla R.R. Colunga-Pedraza, Edgar Ulises Ulises Coronado-Alejandro, Luz María Barbosa Castillo, Fernando De La Garza, Eliezer Tomas Tomas Gomez Gomez, Andres Gomez-De Leon, Julia Esther Colunga Pedraza, Cesar Homero Gutierrez-Aguirre, Olga Graciela Cantú Rodriguez, David Gomez-Almaguer
Publikováno v:
Blood. 140:12886-12887
Autor:
José Carlos Jaime-Pérez, Jorge Valdespino-Valdes, Andrés Gómez-De León, Renata Valeria Barragán-Longoria, Adriana Dominguez-Villanueva, Olga Graciela Cantú-Rodríguez, César Homero Gutiérrez-Aguirre, David Gómez-Almaguer
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
BackgroundHematopoietic cell transplantation (HCT) increases survival for acute leukemia. Outpatient allogeneic HCT reduces costs and increases transplant rates in developing countries. We report outcomes of outpatient HLA-identical and haploidentica
Externí odkaz:
https://doaj.org/article/fe2d6b6e81d248bdb867b68e33798ff3
Autor:
Moisés Manuel Gallardo-Pérez, César Homero Gutiérrez-Aguirre, Juan Carlos Olivares-Gazca, Guillermo José Ruiz-Argüelles
Publikováno v:
Hematology, Vol 29, Iss 1 (2024)
ABSTRACTHaploidentical hematopoietic can be conducted on an outpatient basis but the two main reasons to accept into the hospital a patient in this setting are complications of the hematological toxicity and/or the cytokine-release syndrome. With the
Externí odkaz:
https://doaj.org/article/d7ab91357a1948cc9ac543b4f56bc62f
Autor:
Perla R. Colunga-Pedraza, Ana Varela-Constantino, Andrés Gómez-De León, Gerardo A De la Rosa-Flores, Olga G. Cantu-Rodriguez, Cesar Homero Gutierrez-Aguirre, Julia E. Colunga-Pedraza, Samantha P. Peña-Lozano, Consuelo Mancias-Guerra, Yajaira Valentine Jimenez-Antolinez, David Gómez-Almaguer
Publikováno v:
Transplantation and Cellular Therapy. 28:S156
Autor:
Diana E Garcia-Camarillo, Cesar Homero Gutierrez Aguirre, Andrés Gómez-De León, Paola Santana-Hernandez, Perla R. Colunga-Pedraza, David Gómez-Almaguer, Olga G. Cantú-Rodríguez
Publikováno v:
Biology of Blood and Marrow Transplantation. 25:S171-S172
Introduction Donor lymphocyte infusion (DLI) is a useful therapy for mixed chimerism (MC) and measurable residual disease (MRD) after allogeneic transplantation (HSCT). Multiple DLI products can be obtained through apheresis and cryopreservation, but
Autor:
Consuelo Mancías-Guerra, MD, Sandra Abigail Sánchez-García, Sofía Alejandra Carreño-Salcedo, Cesar Homero Gutiérrez-Aguirre, MD
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 45, Iss 1, Pp 106-109 (2023)
Externí odkaz:
https://doaj.org/article/50fae33891554b659d8e71c2b9d48e35
Autor:
Luz del Carmen Tarín Arzaga, Julia Esther Colunga Pedraza, Emmanuel Bugarin Estrada, Olga Graciela Cantu Rodriguez, David Gómez-Almaguer, Perla R. Colunga Pedraza, Andrés Gómez-De León, Cesar Homero Gutierrez Aguirre, José Miguel Yañez Reyes, Paola Santana-Hernandez
Publikováno v:
Blood. 132:3355-3355
Introduction: Our center has implemented an outpatient-based peripheral blood haploidentical HSCT (haplo-HSCT) program since 2012. Cytokine release syndrome (CRS) associated with T-cell replete haplo-HSCT is characterized by fever and high levels of
Autor:
Cesar Homero Gutierrez Aguirre, Consuelo Mancias, Miguel Herrera-Rojas, Olga Graciela Cantu Rodriguez, Luz del Carmen Tarín Arzaga, Jose Angel Hawing, David Gómez-Almaguer, Andrés Gómez-De León, Lourdes Garza-Ocañas
Publikováno v:
Blood. 132:3363-3363
Introduction: Numerous clinical trials have been conducted in order to reduce or prevent the appearance of mucositis in patients undergoing cancer treatment and some of these have appeared in the clinical guidelines as recommendations (Keefe,DM Cance
Autor:
David Gómez-Almaguer, Oscar Marquez-Pinedo, Andrés Gómez-De León, Cesar Homero Gutierrez Aguirre, Paola Santana-Hernandez, Luz del Carmen Tarín Arzaga, Olga Graciela Cantu Rodriguez, Diana E Garcia-Camarillo, César Cantú, Perla R. Colunga Pedraza
Publikováno v:
Blood. 132:1043-1043
Introduction: Pernicious anemia is the leading cause of vitamin B12 deficiency worldwide, caused by an autoimmune reaction against parietal cells in the gastric mucosa leading to B12 absorption impairment. The treatment of pernicious anemia is based